Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Y-Mabs Therapeutics Inc shares valued at $64,116 were sold by Gad Thomas on Mar 05 ’24. At $16.44 per share, Gad Thomas sold 3,900 shares. The insider’s holdings dropped to 158,700 shares worth approximately $2.62 million following the completion of this transaction.
Also, Rajah Vignesh sold 1,711 shares, netting a total of over 28,283 in proceeds. Following the sale of shares at $16.53 each, the insider now holds 33,889 shares.
Before that, Smith Susan Laura had sold 1,682 shares from its account. In a trade valued at $27,837, the SVP & CHIEF COMMERCIAL OFFICER traded Y-Mabs Therapeutics Inc shares for $16.55 each. Upon closing the transaction, the insider’s holdings decreased to 1,682 shares, worth approximately $0.56 million.
As published in a research note from Wedbush on May 10, 2023, Y-Mabs Therapeutics Inc [YMAB] has been rated up from a Neutral to an Outperform and the price target has been revised to $13 from $5. Analysts at Guggenheim downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early April. As of January 27, 2023, Morgan Stanley has decreased its “an Equal-weight” rating to a “an Underweight” for YMAB. Earlier on January 05, 2023, Cowen downgraded its rating. Their new recommendation was “a Market perform” for YMAB stock which previously was a “an Outperform”.
Analyzing YMAB Stock Performance
During the last five days, there has been a surge of approximately 7.85%. Over the course of the year, Y-Mabs Therapeutics Inc shares have jumped approximately 141.79%. Shares of the company reached a 52-week high of $20.90 on 03/01/24 and a 52-week low of $6.48 on 01/03/24. A 50-day SMA is recorded $15.70, while a 200-day SMA reached $9.14. Nevertheless, trading volume fell to 0.37 million shares from 0.21 million shares the previous day.
Support And Resistance Levels for Y-Mabs Therapeutics Inc (YMAB)
According to the 24-hour chart, there is a support level at 15.57, which, if violated, would cause prices to drop to 14.64. In the upper region, resistance lies at 17.21. The next price resistance is at 17.92. RSI (Relative Strength Index) is 61.84 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.58, which suggests the price will decrease in the coming days. Percent R is at 17.35%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
